Does the implementation of KDIGO guidelines reduce the frequency and severity of AKI in biomarker-identified high-risk patients undergoing cardiac surgery?
Implementing KDIGO guidelines in biomarker-identified high-risk patients reduces the frequency and severity of AKI after cardiac surgery.
An implementation of the KDIGO guidelines compared with standard care reduced the frequency and severity of AKI after cardiac surgery in high risk patients. Adequately powered multicenter trials are warranted to examine mortality and long-term renal outcomes.
Meersch et al. (Sat,) studied this question.